Garlic, silver bullets, and surveillance upper endoscopy for barrett's esophagus

Gastroenterology

Volumn 145, Issue 2, 2013, Pages 273-276

  Shaheen, Nicholas J ^a,b   Hur, Chin ^a,b  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BARRETT ESOPHAGUS; CANCER MORTALITY; CANCER RISK; CANCER SCREENING; CANCER SUSCEPTIBILITY; CAUSE OF DEATH; CLINICAL EFFECTIVENESS; EARLY CANCER; ESOPHAGEAL ADENOCARCINOMA; ESOPHAGOSCOPY; ESOPHAGUS BIOPSY; HUMAN; PRECANCER; PRIORITY JOURNAL; REVIEW; SURVEILLANCE UPPER ENDOSCOPY;

EID: 84880637374     PISSN: 00165085     EISSN: 15280012     Source Type: Journal    
DOI: 10.1053/j.gastro.2013.06.028     Document Type: Editorial

References (26)

1. J.M. Inadomi, R. Sampliner, and J. Lagergren Screening and surveillance for Barrett esophagus in high-risk groups: a cost-utility analysis Ann Intern Med 138 2003 176 186
2. D.A. Corley, T.R. Levin, and L.A. Habel Surveillance and survival in Barrett's adenocarcinomas: a population-based study Gastroenterology 122 2002 633 640
3. D.A. Corley, K. Mehtani, and C. Quesenberry Impact of endoscopic surveillance on mortality from Barrett's esophagus-associated esophageal adenocarcinomas Gastroenterology 145 2013 312 319
4. S.J. Spechler, P. Sharma, and R.F. Souza American Gastroenterological Association medical position statement on the management of Barrett's esophagus Gastroenterology 140 2011 1084 1091
5. K.K. Wang, and R.E. Sampliner Updated guidelines 2008 for the diagnosis, surveillance and therapy of Barrett's esophagus Am J Gastroenterol 103 2008 788 797
6. W.K. Hirota, M.J. Zuckerman, and D.G. Adler ASGE guideline: the role of endoscopy in the surveillance of premalignant conditions of the upper GI tract Gastrointest Endosc 63 2006 570 580
7. G.W. Falk, T.M. Ours, and J.E. Richter Practice patterns for surveillance of Barrett's esophagus in the united states Gastrointest Endosc 52 2000 197 203
8. J.M.J. Streitz, C.W.J. Andrews, and F.H. Ellis Jr. Endoscopic surveillance of Barrett's esophagus. Does it help? J Thorac Cardiovasc Surg 105 1993 383 387
9. J.H. Peters, G.W. Clark, and A.P. Ireland Outcome of adenocarcinoma arising in Barrett's esophagus in endoscopically surveyed and nonsurveyed patients J Thorac Cardiovasc Surg 108 1994 813 821
10. J.W. van Sandick, J.J. van Lanschot, and B.W. Kuiken Impact of endoscopic biopsy surveillance of Barrett's oesophagus on pathological stage and clinical outcome of Barrett's carcinoma Gut 43 1998 216 222
11. G.S. Cooper, T.D. Kou, and A. Chak Receipt of previous diagnoses and endoscopy and outcome from esophageal adenocarcinoma: a population-based study with temporal trends Am J Gastroenterol 104 2009 1356 1362
12. M. Solaymani-Dodaran, T.R. Card, and J. West Cause-specific mortality of people with Barrett's esophagus compared with the general population: a population-based cohort study Gastroenterology 144 2013 1375 1383
13. C.E. Macdonald, A.C. Wicks, and R.J. Playford Final results from 10 year cohort of patients undergoing surveillance for Barrett's oesophagus: observational study BMJ 321 7271 2000 1252 1255
14. P. Moayyedi, N. Burch, and N. Khtar-Danesh Mortality rates in patients with Barrett's oesophagus Aliment Pharmacol Ther 27 2008 316 320
15. A. Dubecz, I. Gall, and N. Solymosi Temporal trends in long-term survival and cure rates in esophageal cancer: a SEER database analysis J Thorac Oncol 7 2012 443 447
16. S.S. Buys, E. Partridge, and A. Black Effect of screening on ovarian cancer mortality: the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening randomized controlled trial JAMA 305 2011 2295 2303
17. R. Chou, J.M. Croswell, and T. Dana Screening for prostate cancer: a review of the evidence for the U.S. Preventive Services Task Force Ann Intern Med 155 2011 762 771
18. C. Hur, M. Miller, and C.Y. Kong Trends in esophageal adenocarcinoma incidence and mortality Cancer 119 2013 1149 1158
19. D.C. Farrow, T.L. Vaughan, and C. Sweeney Gastroesophageal reflux disease, use of H2 receptor antagonists, and risk of esophageal and gastric cancer Cancer Causes Control 11 2000 231 238
20. W.H. Chow, W.D. Finkle, and J.K. McLaughlin The relation of gastroesophageal reflux disease and its treatment to adenocarcinomas of the esophagus and gastric cardia JAMA 274 1995 474 477
21. J. Lagergren, R. Bergstrom, and A. Lindgren Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma [see comments] N Engl J Med 340 1999 825 831
22. B.A. Jobe, J.G. Hunter, and E.Y. Chang Office-based unsedated small-caliber endoscopy is equivalent to conventional sedated endoscopy in screening and surveillance for Barrett's esophagus: a randomized and blinded comparison Am J Gastroenterol 101 2006 2693 2703
23. A.F. Peery, T. Hoppo, and K.S. Garman Feasibility, safety, acceptability, and yield of office-based, screening transnasal esophagoscopy Gastrointest Endosc 75 2012 945 953
24. S.R. Kadri, P. Lao-Sirieix, and M. O'Donovan Acceptability and accuracy of a non-endoscopic screening test for Barrett's oesophagus in primary care: cohort study BMJ 341 2010 c4372
25. M.J. Gora, J.S. Sauk, and R.W. Carruth Tethered capsule endomicroscopy enables less invasive imaging of gastrointestinal tract microstructure Nat Med 19 2013 238 240
26. J.H. Rubenstein, A. Sonnenberg, and J. Davis Effect of a prior endoscopy on outcomes of esophageal adenocarcinoma among United States veterans Gastrointest Endosc 68 2008 849 855